| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $14,674,768 | 7 | 100 |
| Walter Matthew R. | SVP, Chief HR Officer | 0 | $0 | 1 | $257,931 | $-257,931 |
| Marinaro Michael | EVP, Pres MedSurg and Americas | 0 | $0 | 1 | $1M | $-1M |
| Smith Gregory L | EVP Global Ops & Supply Chain | 0 | $0 | 1 | $3.06M | $-3.06M |
| Martha Geoffrey | Chairman and CEO | 0 | $0 | 1 | $4.75M | $-4.75M |
| KIIL HARRY SKIP | EVP & President Cardiovascular | 0 | $0 | 3 | $5.61M | $-5.61M |
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac …
Over the last 12 months, insiders at Medtronic Plc have bought $0 and sold $14.67M worth of Medtronic Plc stock.
On average, over the past 5 years, insiders at Medtronic Plc have bought $490,041 and sold $5.36M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,500 shares for transaction amount of $230,925 was made by Jellison William R (director) on 2025‑08‑25.
| 2026-10-15 | Sale | Martha Geoffrey | Chairman and CEO | 50,000 0.0039% | $95.00 | $4.75M | -0.69% | |
| 2026-10-15 | Sale | Marinaro Michael | EVP, Pres MedSurg and Americas | 10,420 0.0008% | $96.00 | $1M | -0.69% | |
| 2026-09-16 | Sale | KIIL HARRY SKIP | EVP & President Cardiovascular | 1,483 0.0001% | $93.65 | $138,883 | +0.14% | |
| 2026-07-08 | Sale | Walter Matthew R. | SVP, Chief HR Officer | 3,102 0.0002% | $83.15 | $257,931 | +10.67% | |
| 2026-06-08 | Sale | KIIL HARRY SKIP | EVP & President Cardiovascular | 4,189 0.0003% | $80.44 | $336,965 | +11.55% | |
| 2026-02-19 | Sale | KIIL HARRY SKIP | EVP & President Cardiovascular | 52,524 0.0041% | $97.71 | $5.13M | -10.13% | |
| 2025-11-19 | Sale | Smith Gregory L | EVP Global Ops & Supply Chain | 30,000 0.0024% | $101.95 | $3.06M | -8.30% | |
| 2025-09-03 | Sale | KIIL HARRY SKIP | EVP & President Cardiovascular | 8,605 0.0007% | $91.58 | $788,048 | +1.47% | |
| 2025-08-25 | Jellison William R | director | 2,500 0.0002% | $92.37 | $230,925 | +1.40% | ||
| 2025-08-22 | Jellison William R | director | 2,500 0.0002% | $92.73 | $231,825 | +0.26% | ||
| 2025-01-24 | Sale | Wall Brett A. | EVP & Pres Neuroscience | 12,437 0.001% | $90.00 | $1.12M | +3.07% | |
| 2025-01-08 | Sale | Wall Brett A. | EVP & Pres Neuroscience | 9,850 0.0007% | $80.41 | $792,039 | +11.54% | |
| 2024-06-07 | Sale | Martha Geoffrey | Chairman and CEO | 19,113 0.0015% | $83.77 | $1.6M | +5.01% | |
| 2024-04-08 | Sale | Marinaro Michael | EVP & President, Surgical OU | 854 <0.0001% | $83.14 | $71,002 | +5.08% | |
| 2024-02-21 | Sale | Salmon Sean | EVP & President Cardiovascular | 30,695 0.0023% | $85.13 | $2.61M | -0.88% | |
| 2023-12-19 | Sale | Wall Brett A. | EVP & Pres Neuroscience | 4,997 0.0004% | $82.17 | $410,603 | +3.65% | |
| 2023-08-23 | Sale | Smith Gregory L | EVP Global Ops & Supply Chain | 10,000 0.0008% | $83.84 | $838,400 | -0.41% | |
| 2023-08-14 | Sale | Wall Brett A. | EVP & Pres Neuroscience | 1,000 <0.0001% | $83.38 | $83,380 | -0.05% | |
| 2023-08-04 | Sale | Marinaro Michael | EVP & President, Surgical OU | 1,352 0.0001% | $84.11 | $113,717 | -1.26% | |
| 2023-07-14 | Sale | Wall Brett A. | EVP & Pres Neuroscience | 2,000 0.0002% | $87.97 | $175,940 | -4.83% |
| ISHRAK OMAR | Executive Chairman | 561032 0.0439% | $55.47M | 2 | 7 | +5.03% |
| ANDERSON RICHARD H | director | 108374 0.0085% | $10.72M | 6 | 0 | +0.88% |
| POZEN ROBERT C | director | 60964 0.0048% | $6.03M | 1 | 1 | +11.67% |
| Lenehan James T | director | 47028 0.0037% | $4.65M | 1 | 1 | +7.58% |
| PARKHILL KAREN L | EVP & Chief Financial Officer | 34946 0.0027% | $3.46M | 1 | 6 | +19.17% |
| Jellison William R | director | 5000 0.0004% | $494,400.00 | 2 | 0 | +0.83% |
| Increased Positions | 1,173 | +50.74% | 52M | +4.79% |
| Decreased Positions | 1,021 | -44.16% | 45M | -4.15% |
| New Positions | 269 | New | 6M | New |
| Sold Out Positions | 112 | Sold Out | 3M | Sold Out |
| Total Postitions | 2,464 | +6.57% | 1B | +0.64% |
| Vanguard Group Inc | $12.21M | 9.91% | 127.07M | +163,556 | +0.13% | 2025-09-30 |
| Blackrock, Inc. | $11.48M | 9.33% | 119.57M | -3M | -2.35% | 2025-09-30 |
| State Street Corp | $5.81M | 4.72% | 60.46M | +625,992 | +1.05% | 2025-09-30 |
| Jpmorgan Chase & Co | $5.01M | 4.07% | 52.2M | +17M | +48.86% | 2025-09-30 |
| Capital Research Global Investors | $2.95M | 2.39% | 30.69M | -6M | -15.59% | 2025-09-30 |
| Geode Capital Management, Llc | $2.66M | 2.16% | 27.65M | -579,444 | -2.05% | 2025-09-30 |
| Bank Of America Corp /De/ | $2.33M | 1.89% | 24.25M | +2M | +9.36% | 2025-09-30 |
| Bank Of New York Mellon Corp | $2.06M | 1.68% | 21.47M | +192,410 | +0.9% | 2025-09-30 |
| Massachusetts Financial Services Co /Ma/ | $2.03M | 1.65% | 21.09M | +98,220 | +0.47% | 2025-09-30 |
| Morgan Stanley | $1.94M | 1.58% | 20.23M | +1M | +6.35% | 2025-09-30 |